Lindbrook Capital, LLC Kintara Therapeutics, Inc. Transaction History

Lindbrook Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.14 - $0.5 $298 - $1,067	-2,135 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$0.82 - $2.3 $2,460 - $6,899	-3,000 Reduced 58.42%	2,135 $2,000
Q2 2021 Jul 27, 2021	BUY	$1.26 - $2.4 $1,260 - $2,400	1,000 Added 24.18%	5,135 $12,000
Q1 2021 Apr 28, 2021	BUY	$1.32 - $2.74 $4,138 - $8,589	3,135 Added 313.5%	4,135 $7,000
Q4 2020 Jan 27, 2021	BUY	$1.26 - $1.72 $1,260 - $1,720	1,000 New	1,000 $1,000

Ticker KTRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,807,296
Market Cap $17.8M
Description
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme,...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.